Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional Results available

A Study to Assess the Efficacy and Safety of Enteric-Coated Acetylsalicylic Acid in Patients at Moderate Risk of Cardiovascular Disease

ClinicalTrials.gov ID: NCT00501059

Public ClinicalTrials.gov record NCT00501059. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 23, 2026, 5:53 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Double-Blind, Placebo-Controlled, Multi-Center, Parallel Group Study to Assess the Efficacy (Reduction of Cardiovascular Disease Events) and Safety of 100 mg Enteric-Coated Acetylsalicylic Acid in Patients at Moderate Risk of Cardiovascular Disease

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The use of acetylsalicylic acid in the primary prevention of cardiovascular events has been extensively studied but to a lesser extent in patients with moderate levels of cardiovascular risk. The current study is designed to prove the efficacy and tolerability of 100 mg enteric-coated Aspirin versus placebo in the prevention of cardiovascular disease (CVD) events, which include fatal and nonfatal myocardial infarction, fatal and nonfatal stroke and CV death, in a population with no history of known CVD who are at moderate risk of major CHD events (approximately 10-20% 10 year CHD risk). This corresponds to a patient population mean 10-year CVD risk of approximately 30%. Subjects are treated in a standard care setting and may receive treatment for the underlying risk factors as defined by the treating physician. Outcome events will be adjudicated by an Endpoint Adjudication Committee and the study will be monitored by an independent Data Safety Monitoring Board.

Study identification

NCT ID
NCT00501059
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Bayer
Industry
Enrollment
12,546 participants

Conditions and interventions

Eligibility (public fields only)

Age range
55 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jul 5, 2007 (Actual)
Primary completion
Nov 15, 2016 (Actual)
Completion
Nov 15, 2016 (Actual)
Last update posted
Oct 26, 2018

2007 – 2016

United States locations

U.S. sites
73
U.S. states
22
U.S. cities
70
Facility City State ZIP Site status
Not listed Birmingham Alabama 39294 —
Not listed Graysville Alabama 35073 —
Not listed Pell City Alabama 35125 —
Not listed Phoenix Arizona 85051 —
Not listed Scottsdale Arizona 85260 —
Not listed Tucson Arizona 85712 —
Not listed Hot Springs Arkansas 71913-4457 —
Not listed Fremont California 94536-3702 —
Not listed Huntington Park California 90255 —
Not listed Los Angeles California 90025 —
Not listed Rancho Cucamonga California 91730 —
Not listed Rolling Hills Estates California 90274 —
Helping Hands Clinical Trials Santa Ana California 92704 —
Not listed Newark Delaware 19702 —
Medical Research Trust Boynton Beach Florida 33426 —
Not listed Gainesville Florida 32601 —
Not listed Hialeah Florida 33016 —
Medical Research Centers of South Florida, Inc. Hollywood Florida 33021 —
Office of Dr.Larry Levinson, DO Hollywood Florida 33021 —
Not listed Kissimmee Florida 34741 —
Not listed Largo Florida 33770 —
Not listed Marianna Florida 32446-2120 —
Not listed Panama City Florida 32401 —
Tallahassee Memorial Family Quincy Florida 32351 —
Not listed Tampa Florida 33614 —
Not listed Atlanta Georgia 30318 —
Not listed Chicago Illinois 60628 —
Not listed Chicago Illinois 60631-1958 —
Not listed Lockport Illinois 60491 —
Not listed Vernon Hills Illinois 60061 —
Not listed Evansville Indiana 47713 —
Not listed Fort Wayne Indiana 46804 —
Not listed Lebanon Kentucky 40033 —
Not listed Prince Frederick Maryland 20678 —
Not listed Bridgman Michigan 49106 —
Not listed Cadillac Michigan 49601 —
Not listed Interlochen Michigan 49643-9264 —
Not listed Troy Michigan 48085 —
Not listed Port Gibson Mississippi 39150 —
Not listed Florissant Missouri 63031 —
Not listed Broken Bow Nebraska 68822 —
Not listed Omaha Nebraska 68114 —
Not listed Omaha Nebraska 68116-2004 —
Not listed Belvidere New Jersey 07823 —
Not listed Cherry Hill New Jersey 08084 —
Not listed Clifton New Jersey 07013 —
Not listed Hainesport New Jersey 08036 —
Not listed Jersey City New Jersey 07306 —
Not listed Lawrenceville New Jersey 08648 —
Not listed Linden New Jersey 07036 —
PharmaTrials, Inc. Perth Amboy New Jersey 08861 —
Not listed Stratford New Jersey 08084 —
Not listed Burlington North Carolina 27215 —
Not listed Columbus North Carolina 28722 —
Not listed Greensboro North Carolina 27401 —
Not listed Raleigh North Carolina 27609 —
Not listed Carlisle Ohio 45005-3320 —
Not listed Marion Ohio 43302 —
Not listed Montgomery Ohio 45242 —
Not listed Perrysburg Ohio 43551 —
Not listed Doylestown Pennsylvania 18901 —
Not listed Duncansville Pennsylvania 16635 —
Not listed Sellersville Pennsylvania 18960 —
Not listed Taylors South Carolina 29687 —
Not listed Daingerfield Texas 75638 —
Not listed McKinney Texas 75069 —
Not listed Rockwall Texas 75032 —
Not listed San Antonio Texas 78205-1116 —
Not listed San Marcos Texas 78666 —
Not listed Stephenville Texas 76401 —
Not listed Sugar Land Texas 77478 —
Not listed Honaker Virginia 24260 —
Merit Medical Group, Inc. Richlands Virginia 24641-2067 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 393 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00501059, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 26, 2018 · Synced Oct 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT00501059 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →